GSK unit ViiV raises outlook on long-term HIV therapies
|
ViiV Healthcare, majority owned by GSK (NYSE:GSK), has
raised its medium-term growth outlook mainly due to the strength of its
long-acting HIV ... |
Study highlights importance of early interventions to combat HIV
A study has compared the development of HIV reservoirs—locations in the body where the virus persists in a latent state—between patients who ... View article...